Clinical Trials Directory

Trials / Completed

CompletedNCT03486925

Oxytocin Effect on Attention Inhibition

An Eye-tracking Study to Investigate Oxytocin Effect on Attention Inhibition

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
71 (actual)
Sponsor
University of Electronic Science and Technology of China · Academic / Other
Sex
Male
Age
18 Years – 30 Years
Healthy volunteers
Accepted

Summary

Effects of intranasal oxytocin (24IU) on cognitive control of attention

Detailed description

The cognitive control of attention towards neutral and emotional stimuli represents a key functional domain and disruptions in this domain have been associated with a range of psychiatric disorders. Saccadic eye movement tasks have been used to assess individual differences in the cognitive control of attention and alterations in psychiatric disorders. Recent evidence suggests that the hypothalamic neuropeptide Oxytocin (OXT) may modulate attention allocation and regulation. To this end the present randomized between-subject placebo-controlled experiment examined whether intranasal OXT modulates behavior in an eye-tracking saccade / anti-saccade paradigm in healthy male subjects. The paradigm used non-social (neutral shape) as well as social (happy, sad, angry, fear, and neutral faces) stimuli to explore emotion-specific effects of OXT.

Conditions

Interventions

TypeNameDescription
DRUGoxytocin treatmentintranasal administration of oxytocin (24IU)
DRUGplacebo treatmentintranasal administration of placebo

Timeline

Start date
2017-12-19
Primary completion
2018-07-20
Completion
2018-08-28
First posted
2018-04-03
Last updated
2019-03-04

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03486925. Inclusion in this directory is not an endorsement.